Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Free Cash Flow (2021 - 2025)

Cingulate's (CINGW) quarterly Free Cash Flow came in at -$3.8 million in Q4 2025, up 12.26% on a YoY basis from -$3.3 million in Q4 2024, and up 11.56% quarter-over-quarter from -$4.2 million in Q3 2025.

Analysis

Cingulate (CINGW) Free Cash Flow (2021 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Free Cash Flow for 5 consecutive years, with -$3.8 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 12.26% year-over-year to -$3.8 million; the trailing twelve-month figure through Dec 2025 stood at -$17.4 million (up 6.76% YoY), and the FY2025 full-year result was -$17.4 million, up 6.73% from the prior year.
  • Free Cash Flow climbed to -$3.8 million in Q4 2025 per CINGW's latest filing, from -$4.2 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$1.6 million in Q2 2021 and bottomed at -$8.8 million in Q1 2024.
  • Historically, Free Cash Flow has averaged -$3.9 million across 5 years, with a median of -$4.1 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Free Cash Flow tumbled 180.46% in 2022, then surged 59.14% in 2024.
  • Over 5 years, Free Cash Flow stood at -$5.3 million in 2021, then grew by 18.44% to -$4.3 million in 2022, then surged by 36.79% to -$2.7 million in 2023, then plunged by 55.6% to -$4.3 million in 2024, then gained by 12.26% to -$3.8 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$3.8 million, -$4.2 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Johnson & Johnson 646.24 Bn 625.48 Bn 17.26 Bn 7.30 Bn
2 AbbVie 441.52 Bn 434.96 Bn 12.70 Bn 3.11 Bn
3 Merck 365.75 Bn 358.60 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 266.61 Bn 258.92 Bn 11.24 Bn 6.20 Bn
5 Pfizer 159.09 Bn 147.39 Bn 10.94 Bn 302.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 44.04 Bn 44.04 Bn - -389.61 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 495.25 Mn
9 United Therapeutics 21.43 Bn 18.77 Bn 683.80 Mn 205.60 Mn
10 Cingulate 100,214.03 100,214.03 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.75 Mn
Sep 30, 2025 -4.24 Mn
Jun 30, 2025 -4.80 Mn
Mar 31, 2025 -4.61 Mn
Dec 31, 2024 -4.28 Mn
Sep 30, 2024 -3.68 Mn
Jun 30, 2024 -1.88 Mn
Mar 31, 2024 -8.83 Mn
Dec 31, 2023 -2.75 Mn
Sep 30, 2023 -4.29 Mn
Jun 30, 2023 -4.60 Mn
Mar 31, 2023 -3.61 Mn
Dec 31, 2022 -4.35 Mn
Sep 30, 2022 -3.40 Mn
Jun 30, 2022 -4.41 Mn
Mar 31, 2022 -3.87 Mn
Dec 31, 2021 -5.33 Mn
Sep 30, 2021 -2.60 Mn
Jun 30, 2021 -1.57 Mn
Mar 31, 2021 -1.74 Mn